These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28710326)

  • 1. Cortical influences drive amyotrophic lateral sclerosis.
    Eisen A; Braak H; Del Tredici K; Lemon R; Ludolph AC; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):917-924. PubMed ID: 28710326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.
    Ferraro PM; Jester C; Olm CA; Placek K; Agosta F; Elman L; McCluskey L; Irwin DJ; Detre JA; Filippi M; Grossman M; McMillan CT
    Neurobiol Aging; 2018 Aug; 68():85-92. PubMed ID: 29751289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
    Vucic S; Cheah BC; Kiernan MC
    Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.
    Geevasinga N; Menon P; Nicholson GA; Ng K; Howells J; Kril JJ; Yiannikas C; Kiernan MC; Vucic S
    JAMA Neurol; 2015 Nov; 72(11):1268-74. PubMed ID: 26348842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
    Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
    J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis.
    Menon P; Kiernan MC; Vucic S
    PLoS One; 2014; 9(1):e87124. PubMed ID: 24475241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical hyperexcitability evolves with disease progression in ALS.
    Menon P; Higashihara M; van den Bos M; Geevasinga N; Kiernan MC; Vucic S
    Ann Clin Transl Neurol; 2020 May; 7(5):733-741. PubMed ID: 32304186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical contributions to the flail leg syndrome: Pathophysiological insights.
    Menon P; Geevasinga N; Yiannikas C; Kiernan MC; Vucic S
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):389-96. PubMed ID: 26888565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology of Speech Network Distinguishes Bulbar From Nonbulbar Amyotrophic Lateral Sclerosis.
    Shellikeri S; Keith J; Black SE; Zinman L; Yunusova Y
    J Neuropathol Exp Neurol; 2020 Mar; 79(3):284-295. PubMed ID: 31951003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
    Vucic S; Kiernan MC
    Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.
    Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S
    Eur J Neurol; 2017 Jun; 24(6):816-824. PubMed ID: 28436181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS.
    Vucic S; Pavey N; Haidar M; Turner BJ; Kiernan MC
    Neurosci Lett; 2021 Aug; 759():136039. PubMed ID: 34118310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis.
    Schuster C; Kasper E; Dyrba M; Machts J; Bittner D; Kaufmann J; Mitchell AJ; Benecke R; Teipel S; Vielhaber S; Prudlo J
    Neurobiol Aging; 2014 Jan; 35(1):240-6. PubMed ID: 23992619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis.
    Geevasinga N; Menon P; Yiannikas C; Kiernan MC; Vucic S
    Eur J Neurol; 2014 Dec; 21(12):1451-7. PubMed ID: 24698287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic lateral sclerosis; clinical features, differential diagnosis and pathology.
    Van Es MA
    Int Rev Neurobiol; 2024; 176():1-47. PubMed ID: 38802173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multisystem degeneration amyotrophic lateral sclerosis - neuropathological staging and clinical translation.
    Verde F; Del Tredici K; Braak H; Ludolph A
    Arch Ital Biol; 2017 Dec; 155(4):118-130. PubMed ID: 29405032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extramotor disorders in amyotrophic lateral sclerosis: multisystem disease?].
    Cellura E
    Clin Ter; 2011; 162(5):457-9. PubMed ID: 22041805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality.
    Bede P; Bokde A; Elamin M; Byrne S; McLaughlin RL; Jordan N; Hampel H; Gallagher L; Lynch C; Fagan AJ; Pender N; Hardiman O
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):766-73. PubMed ID: 23085933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?
    Talbot K
    J Anat; 2014 Jan; 224(1):45-51. PubMed ID: 24010870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.